Page 56 - EJMO-9-3

Eurasian Journal of
Medicine and Oncology NOTCH3 in CSVD and breast cancer

glance. J Cell Sci. 2013;126(Pt 10):2135-2140. doi: 10.1074/jbc.M115.655548
65. Gozlan O, Sprinzak D. Notch signaling in development and 77. Kawazu M, Kojima S, Ueno T, et al. Integrative analysis
homeostasis. Development. 2023;150(4):dev201138. of genomic alterations in triple-negative breast cancer in
association with homologous recombination deficiency.
doi: 10.1242/dev.201138
PLoS Genet. 2017;13(6):e1006853.
66. Vlachakis D, Tsaniras SC, Ioannidou K, Papageorgiou L,
Baumann M, Kossida S. A series of Notch3 mutations in doi: 10.1371/journal.pgen.1006853
CADASIL; insights from 3D molecular modelling and 78. Doebar SC, Sieuwerts AM, de Weerd V, et al. Gene
evolutionary analyses. J Mol Biochem. 2014;3(3):134. expression differences between ductal carcinoma in situ
with and without progression to invasive breast cancer. Am
67. Bray SJ. Notch signalling in context. Nat Rev Mol Cell Biol. J Pathol. 2017;187(7):1648-1655.
2016;17(11):722-735.
doi: 10.1016/j.ajpath.2017.03.012
doi: 10.1038/nrm.2016.94
79. Sansone P, Ceccarelli C, Berishaj M, et al. Self-renewal
68. Xiu MX, Liu YM. The role of oncogenic Notch2 signalling of CD133(hi) cells by IL6/Notch3 signalling regulates
in cancer: A novel therapeutic target. Am J Cancer Res. endocrine resistance in metastatic breast cancer. Nat
2019;9(5):837-854.
Commun. 2016;7:10442.
69. Xia Y, Bhattacharyya A, Roszell EE, Sandig M, doi: 10.1038/ncomms10442
Mequanint K. The role of endothelial cell-bound Jagged1 in
Notch3-induced human coronary artery smooth muscle cell 80. Gu X, Lu C, He D, et al. Notch3 negatively regulates
differentiation. Biomaterials. 2012;33(8):2462-2472. chemoresistance in breast cancers. Tumour Biol.
2016;37(7):9511-9519.
doi: 10.1016/j.biomaterials.2011.12.001
doi: 10.1007/s13277-016-5412-4
70. Xu X, Choi SH, Hu T, et al. Insights into autoregulation of
Notch3 from structural and functional studies of its negative 81. Serafin V, Persano L, Moserle L, et al. Notch3 signalling
regulatory region. Structure. 2015;23(7):1227-1235. promotes tumour growth in colorectal cancer. J Pathol.
2011;224(4):448-460.
doi: 10.1016/j.str.2015.05.001
doi: 10.1002/path.2895
71. Gera S, Dighe RR. The soluble ligand Y box-1 activates
Notch3 receptor by binding to epidermal growth factor like 82. Suliman MA, Zhang Z, Na H, et al. Niclosamide inhibits
repeats 20-23. Arch Biochem Biophys. 2018;660:129-136. colon cancer progression through downregulation of the
Notch pathway and upregulation of the tumour suppressor
doi: 10.1016/j.abb.2018.10.009 miR-200 family. Int J Mol Med. 2016;38(3):776-784.
72. Domenga V, Fardoux P, Lacombe P, et al. Notch3 is required doi: 10.3892/ijmm.2016.2689
for arterial identity and maturation of vascular smooth
muscle cells. Genes Dev. 2004;18(22):2730-2735. 83. Xie T, Li Y, Li SL, Luo HF. Astragaloside IV enhances
cisplatin chemosensitivity in human colorectal cancer via
doi: 10.1101/gad.308904 regulating NOTCH3. Oncol Res. 2016;24(6):447-453.
73. Jin S, Hansson EM, Tikka S, et al. Notch signalling doi: 10.3727/096504016X14685034103590
regulates platelet-derived growth factor receptor-beta
expression in vascular smooth muscle cells. Circ Res. 2008; 84. Wu JK, Adepoju O, De Silva D, et al. A switch in Notch gene
102(12):1483-1491. expression parallels stem cell to endothelial transition in
infantile haemangioma. Angiogenesis. 2010;13(1):15-23.
doi: 10.1161/CIRCRESAHA.107.167965
doi: 10.1007/s10456-009-9161-5
74. Ando K, Wang W, Peng D, et al. Peri-arterial specification of
vascular mural cells from naïve mesenchyme requires Notch 85. Hu L, Xue F, Shao M, Deng A, Wei G. Aberrant expression of
signalling. Development. 2019;146(2):dev165589. Notch3 predicts poor survival for hepatocellular carcinomas.
Biosci Trends. 2013;7(3):152-156.
doi: 10.1242/dev.165589
86. Gramantieri L, Giovannini C, Lanzi A, et al. Aberrant
75. Wang Q, Zhao N, Kennard S, Lilly B. Notch2 and Notch3 Notch3 and Notch4 expression in human hepatocellular
function together to regulate vascular smooth muscle carcinoma. Liver Int. 2007;27(7):997-1006.
development. PLoS One. 2012;7:e37365.
doi: 10.1111/j.1478-3231.2007.01544.x
doi: 10.1371/journal.pone.0037365
87. Man CH, Wei-Man Lun S, et al. Inhibition of NOTCH3
76. Baeten JT, Lilly B. Differential regulation of NOTCH2 and signalling significantly enhances sensitivity to cisplatin
NOTCH3 contribute to their unique functions in vascular in EBV-associated nasopharyngeal carcinoma. J Pathol.
smooth muscle cells. J Biol Chem. 2015;290:16226-16237. 2012;226(3):471-481.

Volume 9 Issue 3 (2025) 48 doi: 10.36922/EJMO025150095